Intermittent nivolumab in the second line warrants further investigation By Sharon Kell|2019-05-23T08:53:27+00:0023 May 2019|Drug treatments| A recent phase 2 trial published in Journal for Immunotherapy [...] Read More Comments Off on Intermittent nivolumab in the second line warrants further investigation